Clopidogrel as the standard of care for elective PCI: Findings from the ALPHEUS

Watch the video and get to know more on ALPHEUS trial. Since Percutaneous coronary intervention (PCI)-related myonecrosis is frequent and can affect the long-term prognosis of patients, then stronger platelet inhibition could potentially lower these events and make the PCI procedure safer.

MAT-BH-2200189/v1/Mar 2022